Stocks
Revalidate Page
Pharma Stocks
Follow pharmaceutical company stocks—blockbuster drugs, patent cliffs, pipeline depth, and pricing policy risks affecting pharma valuations.
Stocks
Novo's series of unfortunate events
Eli wins this round, while Novo continues to flounder.
Stocks
No silver bullet for Novo
Shares sank on the news.
Stocks
Big pharma, big fight
The two pharma companies are duking it out for the future of weight-loss drugs.
Stocks
Slimming down is big business
Both pharma giants are working to create new obesity pills.
Stocks
Pharma Bro declares pharma no-no
Martin Shkreli is shorting a pharmaceutical company, and people are listening to him for some reason.
Stocks
Ozempic slims down its price tag
The Danish pharma giant is desperate to close the gap with Eli Lilly.
Making sense of market moves
Stay up to date on the latest market news with daily analysis of the investing landscape, served up Brew-style.
By subscribing, you accept our Terms & Privacy Policy.